HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of dalfampridine on attacks in patients with episodic ataxia type 2: an observational study.

AuthorsJens Claassen, Julian Teufel, Roger Kalla, Rainer Spiegel, Michael Strupp
JournalJournal of neurology (J Neurol) Vol. 260 Issue 2 Pg. 668-9 (Feb 2013) ISSN: 1432-1459 [Electronic] Germany
PMID23183922 (Publication Type: Case Reports, Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • CACNA1A protein, human
  • Calcium Channels
  • Potassium Channel Blockers
  • 4-Aminopyridine
Topics
  • 4-Aminopyridine (therapeutic use)
  • Adult
  • Ataxia (drug therapy, genetics)
  • Calcium Channels (genetics)
  • Humans
  • Male
  • Middle Aged
  • Nystagmus, Pathologic (drug therapy, genetics)
  • Observation
  • Potassium Channel Blockers (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: